Guardant Health Inc. (GH)
NASDAQ: GH
· Real-Time Price · USD
58.84
-1.52 (-2.52%)
At close: Aug 15, 2025, 3:59 PM
58.50
-0.58%
After-hours: Aug 15, 2025, 07:57 PM EDT
Guardant Health Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 828.85M | 774M | 739.02M | 692.26M | 643.81M | 603.73M | 563.95M | 535.78M | 510.16M | 482.15M | 449.54M | 430.75M | 408.13M | 391.09M | 373.65M | 343.86M | 323.65M | 297.88M |
Cost of Revenue | 308.01M | 299.23M | 289.8M | 131.07M | 114.2M | 95.62M | 83.4M | 211.66M | 194.54M | 177.42M | 156.32M | 142.63M | 132.95M | 126.15M | 122.91M | 117.9M | 108.27M | 100.78M |
Gross Profit | 520.84M | 474.77M | 449.22M | 561.18M | 529.61M | 508.1M | 480.55M | 324.13M | 315.62M | 304.74M | 293.21M | 288.13M | 275.18M | 264.94M | 250.74M | 225.96M | 215.38M | 197.11M |
Operating Income | -460.75M | -454.95M | -443.59M | -515.14M | -511.36M | -530.35M | -564.73M | -513.33M | -544.39M | -555.1M | -544.38M | -496.47M | -459.15M | -426.48M | -411M | -403.96M | -370.92M | -327.9M |
Interest Income | 41.58M | 47.94M | 53.69M | 55.93M | 54.36M | 47.17M | 35.37M | 23.63M | 13.69M | 8.35M | 6.07M | 4.57M | 3.51M | 3.16M | 3.93M | 5.18M | 6.8M | 8.4M |
Pretax Income | -412.74M | -415.38M | -435.09M | -512.38M | -490.27M | -460.05M | -478.76M | -430.51M | -506.78M | -663.49M | -653.45M | -586.42M | -531.97M | -400.47M | -384.47M | -404.95M | -369.12M | -321.34M |
Net Income | -413.82M | -416.55M | -436.37M | -512.41M | -490.76M | -460.9M | -479.45M | -432.34M | -508.23M | -664.89M | -654.59M | -605.57M | -551.1M | -419.24M | -405.67M | -408.5M | -378.65M | -335.71M |
Selling & General & Admin | 624.77M | 577.25M | 545.06M | 505.21M | 463.31M | 453.54M | 451.03M | 453.55M | 469.93M | 474.65M | 463.78M | 444.35M | 423.14M | 401.95M | 398.52M | 399.44M | 390.55M | 356.66M |
Research & Development | 356.82M | 352.47M | 347.75M | 344.07M | 350.61M | 357.87M | 367.19M | 383.92M | 390.08M | 385.18M | 373.81M | 340.25M | 311.2M | 289.47M | 263.22M | 230.48M | 195.76M | 168.35M |
Other Expenses | n/a | n/a | n/a | 227.05M | 227.05M | 227.05M | 227.05M | n/a | n/a | n/a | -48K | -48K | -235K | -478K | -720K | -720K | -188K | 55K |
Operating Expenses | 981.59M | 929.72M | 892.81M | 1.08B | 1.04B | 1.04B | 1.05B | 837.46M | 860.01M | 859.83M | 837.59M | 784.6M | 734.34M | 691.42M | 661.74M | 629.92M | 586.31M | 525.01M |
Interest Expense | 1.1M | 2.73M | 2.58M | 2.58M | 2.58M | 2.58M | 2.58M | 2.58M | 2.58M | 2.58M | 2.58M | 2.58M | 2.58M | 2.58M | 2.58M | 6.67M | 6.03M | 5.4M |
Selling & Marketing Expenses | 426.55M | 388.83M | 364.94M | 339.3M | 310.35M | 299.53M | 295.23M | 297.52M | 308.96M | 311.52M | 299.83M | 278M | 247.86M | 221.97M | 191.88M | 163.57M | 138.44M | 115.74M |
Cost & Expenses | 1.29B | 1.23B | 1.18B | 1.21B | 1.16B | 1.13B | 1.13B | 1.05B | 1.05B | 1.04B | 993.92M | 927.22M | 867.28M | 817.56M | 784.65M | 747.82M | 694.57M | 625.79M |
Income Tax Expense | 1.07M | 1.17M | 1.28M | 27K | 487K | 850K | 685K | 1.83M | 1.45M | 1.4M | 1.14M | 548K | 529K | 166K | 300K | 552K | 524K | 475K |
Shares Outstanding (Basic) | 124.11M | 123.87M | 123.75M | 123.05M | 122.45M | 121.71M | 118.51M | 117.74M | 108.81M | 102.66M | 102.52M | 102.29M | 102.05M | 101.85M | 101.7M | 101.42M | 101.17M | 100.95M |
Shares Outstanding (Diluted) | 124.11M | 123.87M | 123.75M | 123.05M | 122.45M | 121.71M | 118.51M | 117.74M | 108.81M | 102.66M | 102.52M | 102.29M | 102.05M | 101.85M | 101.7M | 101.42M | 101.17M | 100.95M |
EPS (Basic) | -3.35 | -3.39 | -3.56 | -4.24 | -4.09 | -3.92 | -4.28 | -4.06 | -4.91 | -6.49 | -6.4 | -5.93 | -5.41 | -4.12 | -4 | -4.05 | -3.77 | -3.38 |
EPS (Diluted) | -3.35 | -3.39 | -3.56 | -4.24 | -4.09 | -3.92 | -4.28 | -4.06 | -4.91 | -6.49 | -6.4 | -5.93 | -5.41 | -4.12 | -4 | -4.05 | -3.77 | -3.38 |
EBITDA | -413.13M | -397.86M | -390.04M | -466.92M | -444.38M | -414.22M | -433.31M | -385.75M | -463.25M | -621.81M | -614.91M | -551.96M | -501.82M | -373.51M | -359.69M | -377.57M | -343.52M | -296.28M |
EBIT | -411.26M | -414.23M | -432.51M | -509.8M | -487.69M | -457.47M | -476.19M | -427.94M | -504.2M | -660.91M | -650.87M | -583.84M | -529.39M | -397.9M | -381.89M | -398.28M | -363.09M | -315.94M |
Depreciation & Amortization | 5.67M | 16.37M | 42.46M | 42.88M | 43.32M | 43.25M | 42.88M | 42.18M | 40.95M | 39.11M | 35.96M | 31.88M | 27.58M | 24.39M | 22.2M | 20.71M | 19.57M | 19.66M |